Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1374 of 5804
-
New eye drops promise sharper night vision for Post-LASIK patients
Symptom relief CompletedSafety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances.
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could an allergy drug boost brain function in williams syndrome?
Disease control OngoingThis study explores the neurobiological etiology of Williams syndrome and potential therapeutic targets for associated social, motor, and cognitive abnormalities. The main translational objective will be to test the effectiveness of Clemasntine on neurocognitive and other associa…
Phase: PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New 'Sandwich' strategy aims to cut leukemia relapse without donor transplant risks
Disease control Recruiting nowAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main method potentially curing adult B-ALL, but the high treatment-related mortality (NRM) affects overall survival (OS). Autologous stem cell transplantation (auto-HSCT) can significantly reduce NRM but has a …
Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI spots colon polyps in real time, could cut unnecessary biopsies
Diagnosis CompletedColorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death worldwide. Colonoscopy is considered the preferred method of screening for colorectal cancer, and resection of colorectal lesions can significantly reduce the incidenc…
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Could a urea cycle drug help MCAD patients fast longer?
Disease control TerminatedThis is a medical research study to test a medication in patients 10 years of age and older with a disease called medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by the common ACADM c.985 A\>G (K304E) mutation. The medication is sodium phenylbutyrate (ACER-001), whi…
Phase: PHASE2 • Sponsor: Jerry Vockley, MD, PhD • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal stimulation plus arm biking may steady blood pressure after injury
Disease control Recruiting nowSpinal cord injury (SCI) can make it hard for the body to self-regulate some of its automatic functions like blood pressure, breathing, and heart rate. This can also make it hard for those living with SCI to exercise or complete their usual daily activities. The goal of this rand…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Migraine showdown: which drug cuts headaches best?
Symptom relief CompletedInvestigators aim to compare the effect of zonisamide versus topiramate in migraine by assessing the absolute reduction in MMD in each group, the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency
Phase: PHASE3 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Can a new eye drug cut injection frequency for AMD patients?
Disease control Recruiting nowAge-related macular degeneration (AMD) is a degenerative retinal disease. The prognosis of the exudative form was transformed by the introduction of the anti-VEGF monoclonal antibody treatments ranibizumab \[1\] and aflibercept \[2\] in the 2010s. In 2022, a new molecule, Faricim…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Weight-Loss drug liraglutide tested in kids as young as 6
Disease control OngoingThis randomized controlled trial evaluates the efficacy, safety, metabolic, and cardiovascular effects of liraglutide in children aged 6 to 12 years with severe obesity. Participants are randomized to receive liraglutide plus lifestyle intervention or lifestyle intervention alone…
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a light cap boost memory? new trial tests brain photobiomodulation
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if transcranial photobiomodulation (t-PBM), a light-based brain therapy, can help improve memory and cognitive skills in older adults with amnestic mild cognitive impairment (aMCI). This condition involves memory problems that are great…
Phase: NA • Sponsor: Uskudar University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New pill could tame stubborn ulcerative colitis
Disease control OngoingThe main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate any problems. The partici…
Phase: PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Radioactive drug shows promise in High-Risk prostate cancer before surgery
Disease control Recruiting nowTo learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate canc…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Can magnetic pulses sharpen aging brains? new trial aims to find out.
Knowledge-focused Recruiting nowThe proposed research will use closed-loop transcranial magnetic stimulation (TMS) based on individualized brain networks to establish parameters that can reliably control brain states. This will be tested in healthy aging and mild cognitive impairment (MCI) cohorts. The investig…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New registry tracks PRRT outcomes for neuroendocrine cancer patients
Disease control Recruiting nowThe specific aim is of this study is to gain a better understanding of the patient characteristics, treatment responses, survival outcomes, and adverse events associated with PRRT in patients with gastroenteropancreatic primary NETs.
Sponsor: Methodist Health System • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Could a 3-Day pill ease severe postpartum depression?
Symptom relief CompletedThe purpose of this research study is to test the study drug, NORA520, as a possible treatment for severe postpartum depression (PPD). The trial aims to determine: * How well NORA520 is tolerated and what side effects it may cause * If NORA520 reduces depressive symptoms in subj…
Phase: PHASE2 • Sponsor: DuKang Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Speedy gene test aims to give answers on birth defects in just 7 days
Knowledge-focused CompletedThe management of congenital malformations (3% of pregnancies) by prenatal ultrasound represents a real medical challenge. Their prognosis is variable depending on the underlying aetiology. In France, prenatal diagnosis (PND) has long been based on imaging or infectious, metaboli…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can a phone app boost HIV prevention in rural america?
Prevention OngoingThe goal of this clinical trial is to test the efficacy of a mobile app, Combine, to increase the uptake of HIV and STI testing and pre-exposure prophylaxis (PrEP) over 24 months and to assess the effects of different implementation strategies on intervention maintenance among GB…
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 07:55 UTC
-
New rotavirus vaccine passes first safety check in early trial
⭐️ VACCINE ⭐️ CompletedThe Phase I clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in a population ranging from 6 weeks to 59 years of age. The objective of this study is to evaluate the safety of investigational vaccine in healthy adu…
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:03 UTC
-
Poop pills could tame rare liver disease
Disease control Recruiting nowFARGO is a randomised, phase IIa, multi-centre, placebo-controlled trial to compare Faecal Microbiota Transplant (FMT) with placebo in patients with primary sclerosing cholangitis (PSC) and concomitant inflammatory bowel disease.
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Bladder cancer diagnosis: could a simple MRI replace painful biopsies?
Diagnosis Recruiting nowThis is a pilot, single arm, prospective study that aims to validate the accuracy of the VI-RADS score obtained via multi-parametric magnetic resonance imaging (mpMRI) compared to pathologic cancer stage obtained via diagnostic transurethral bladder tumor resection (TURBT) as wel…
Phase: NA • Sponsor: University of California, Irvine • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC